CD274 and neoplasm: Compared with chemotherapy, PD-L1 inhibitors have been reported to prolong PFS and OS, particularly in patients with high tumor PD-L1 expression (Mok et al., 2019; Jassem et al., 2021; Sezer et al., 2021; Herbst et al., 2020).